Report cover image

Global Afatinib Maleate Tablets Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20283793

Description

Summary

According to APO Research, The global Afatinib Maleate Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Afatinib Maleate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Afatinib Maleate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Afatinib Maleate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Afatinib Maleate Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Afatinib Maleate Tablets include Yangtze River Pharm, Qingfeng Medicine Group, Qilu Pharmaceutical, Beacon Pharmaceuticals, Kelun-Kazpharm, Hansoh Pharmaceuticak, Chia Tai-Tianqing and Boehringer Ingelheim International GmbH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Afatinib Maleate Tablets, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Afatinib Maleate Tablets, also provides the revenue of main regions and countries. Of the upcoming market potential for Afatinib Maleate Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Afatinib Maleate Tablets revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Afatinib Maleate Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Afatinib Maleate Tablets revenue, projected growth trends, production technology, application and end-user industry.

Afatinib Maleate Tablets Segment by Company

Yangtze River Pharm
Qingfeng Medicine Group
Qilu Pharmaceutical
Beacon Pharmaceuticals
Kelun-Kazpharm
Hansoh Pharmaceuticak
Chia Tai-Tianqing
Boehringer Ingelheim International GmbH
Afatinib Maleate Tablets Segment by Type

50mg
40mg
30mg
20mg
Afatinib Maleate Tablets Segment by Application

Hospital
Clinic
Others
Afatinib Maleate Tablets Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Afatinib Maleate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Afatinib Maleate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Afatinib Maleate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Afatinib Maleate Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Afatinib Maleate Tablets company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Afatinib Maleate Tablets revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Afatinib Maleate Tablets Market by Type
1.2.1 Global Afatinib Maleate Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 50mg
1.2.3 40mg
1.2.4 30mg
1.2.5 20mg
1.3 Afatinib Maleate Tablets Market by Application
1.3.1 Global Afatinib Maleate Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Afatinib Maleate Tablets Market Dynamics
2.1 Afatinib Maleate Tablets Industry Trends
2.2 Afatinib Maleate Tablets Industry Drivers
2.3 Afatinib Maleate Tablets Industry Opportunities and Challenges
2.4 Afatinib Maleate Tablets Industry Restraints
3 Global Growth Perspective
3.1 Global Afatinib Maleate Tablets Market Perspective (2020-2031)
3.2 Global Afatinib Maleate Tablets Growth Trends by Region
3.2.1 Global Afatinib Maleate Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Afatinib Maleate Tablets Market Size by Region (2020-2025)
3.2.3 Global Afatinib Maleate Tablets Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Afatinib Maleate Tablets Revenue by Players
4.1.1 Global Afatinib Maleate Tablets Revenue by Players (2020-2025)
4.1.2 Global Afatinib Maleate Tablets Revenue Market Share by Players (2020-2025)
4.1.3 Global Afatinib Maleate Tablets Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Afatinib Maleate Tablets Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Afatinib Maleate Tablets Key Players Headquarters & Area Served
4.4 Global Afatinib Maleate Tablets Players, Product Type & Application
4.5 Global Afatinib Maleate Tablets Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Afatinib Maleate Tablets Market CR5 and HHI
4.6.3 2024 Afatinib Maleate Tablets Tier 1, Tier 2, and Tier 3
5 Afatinib Maleate Tablets Market Size by Type
5.1 Global Afatinib Maleate Tablets Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Afatinib Maleate Tablets Revenue by Type (2020-2031)
5.3 Global Afatinib Maleate Tablets Revenue Market Share by Type (2020-2031)
6 Afatinib Maleate Tablets Market Size by Application
6.1 Global Afatinib Maleate Tablets Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Afatinib Maleate Tablets Revenue by Application (2020-2031)
6.3 Global Afatinib Maleate Tablets Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Yangtze River Pharm
7.1.1 Yangtze River Pharm Comapny Information
7.1.2 Yangtze River Pharm Business Overview
7.1.3 Yangtze River Pharm Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.1.4 Yangtze River Pharm Afatinib Maleate Tablets Product Portfolio
7.1.5 Yangtze River Pharm Recent Developments
7.2 Qingfeng Medicine Group
7.2.1 Qingfeng Medicine Group Comapny Information
7.2.2 Qingfeng Medicine Group Business Overview
7.2.3 Qingfeng Medicine Group Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.2.4 Qingfeng Medicine Group Afatinib Maleate Tablets Product Portfolio
7.2.5 Qingfeng Medicine Group Recent Developments
7.3 Qilu Pharmaceutical
7.3.1 Qilu Pharmaceutical Comapny Information
7.3.2 Qilu Pharmaceutical Business Overview
7.3.3 Qilu Pharmaceutical Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.3.4 Qilu Pharmaceutical Afatinib Maleate Tablets Product Portfolio
7.3.5 Qilu Pharmaceutical Recent Developments
7.4 Beacon Pharmaceuticals
7.4.1 Beacon Pharmaceuticals Comapny Information
7.4.2 Beacon Pharmaceuticals Business Overview
7.4.3 Beacon Pharmaceuticals Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.4.4 Beacon Pharmaceuticals Afatinib Maleate Tablets Product Portfolio
7.4.5 Beacon Pharmaceuticals Recent Developments
7.5 Kelun-Kazpharm
7.5.1 Kelun-Kazpharm Comapny Information
7.5.2 Kelun-Kazpharm Business Overview
7.5.3 Kelun-Kazpharm Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.5.4 Kelun-Kazpharm Afatinib Maleate Tablets Product Portfolio
7.5.5 Kelun-Kazpharm Recent Developments
7.6 Hansoh Pharmaceuticak
7.6.1 Hansoh Pharmaceuticak Comapny Information
7.6.2 Hansoh Pharmaceuticak Business Overview
7.6.3 Hansoh Pharmaceuticak Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.6.4 Hansoh Pharmaceuticak Afatinib Maleate Tablets Product Portfolio
7.6.5 Hansoh Pharmaceuticak Recent Developments
7.7 Chia Tai-Tianqing
7.7.1 Chia Tai-Tianqing Comapny Information
7.7.2 Chia Tai-Tianqing Business Overview
7.7.3 Chia Tai-Tianqing Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.7.4 Chia Tai-Tianqing Afatinib Maleate Tablets Product Portfolio
7.7.5 Chia Tai-Tianqing Recent Developments
7.8 Boehringer Ingelheim International GmbH
7.8.1 Boehringer Ingelheim International GmbH Comapny Information
7.8.2 Boehringer Ingelheim International GmbH Business Overview
7.8.3 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Revenue and Gross Margin (2020-2025)
7.8.4 Boehringer Ingelheim International GmbH Afatinib Maleate Tablets Product Portfolio
7.8.5 Boehringer Ingelheim International GmbH Recent Developments
8 North America
8.1 North America Afatinib Maleate Tablets Revenue (2020-2031)
8.2 North America Afatinib Maleate Tablets Revenue by Type (2020-2031)
8.2.1 North America Afatinib Maleate Tablets Revenue by Type (2020-2025)
8.2.2 North America Afatinib Maleate Tablets Revenue by Type (2026-2031)
8.3 North America Afatinib Maleate Tablets Revenue Share by Type (2020-2031)
8.4 North America Afatinib Maleate Tablets Revenue by Application (2020-2031)
8.4.1 North America Afatinib Maleate Tablets Revenue by Application (2020-2025)
8.4.2 North America Afatinib Maleate Tablets Revenue by Application (2026-2031)
8.5 North America Afatinib Maleate Tablets Revenue Share by Application (2020-2031)
8.6 North America Afatinib Maleate Tablets Revenue by Country
8.6.1 North America Afatinib Maleate Tablets Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Afatinib Maleate Tablets Revenue by Country (2020-2025)
8.6.3 North America Afatinib Maleate Tablets Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Afatinib Maleate Tablets Revenue (2020-2031)
9.2 Europe Afatinib Maleate Tablets Revenue by Type (2020-2031)
9.2.1 Europe Afatinib Maleate Tablets Revenue by Type (2020-2025)
9.2.2 Europe Afatinib Maleate Tablets Revenue by Type (2026-2031)
9.3 Europe Afatinib Maleate Tablets Revenue Share by Type (2020-2031)
9.4 Europe Afatinib Maleate Tablets Revenue by Application (2020-2031)
9.4.1 Europe Afatinib Maleate Tablets Revenue by Application (2020-2025)
9.4.2 Europe Afatinib Maleate Tablets Revenue by Application (2026-2031)
9.5 Europe Afatinib Maleate Tablets Revenue Share by Application (2020-2031)
9.6 Europe Afatinib Maleate Tablets Revenue by Country
9.6.1 Europe Afatinib Maleate Tablets Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Afatinib Maleate Tablets Revenue by Country (2020-2025)
9.6.3 Europe Afatinib Maleate Tablets Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Afatinib Maleate Tablets Revenue (2020-2031)
10.2 China Afatinib Maleate Tablets Revenue by Type (2020-2031)
10.2.1 China Afatinib Maleate Tablets Revenue by Type (2020-2025)
10.2.2 China Afatinib Maleate Tablets Revenue by Type (2026-2031)
10.3 China Afatinib Maleate Tablets Revenue Share by Type (2020-2031)
10.4 China Afatinib Maleate Tablets Revenue by Application (2020-2031)
10.4.1 China Afatinib Maleate Tablets Revenue by Application (2020-2025)
10.4.2 China Afatinib Maleate Tablets Revenue by Application (2026-2031)
10.5 China Afatinib Maleate Tablets Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Afatinib Maleate Tablets Revenue (2020-2031)
11.2 Asia Afatinib Maleate Tablets Revenue by Type (2020-2031)
11.2.1 Asia Afatinib Maleate Tablets Revenue by Type (2020-2025)
11.2.2 Asia Afatinib Maleate Tablets Revenue by Type (2026-2031)
11.3 Asia Afatinib Maleate Tablets Revenue Share by Type (2020-2031)
11.4 Asia Afatinib Maleate Tablets Revenue by Application (2020-2031)
11.4.1 Asia Afatinib Maleate Tablets Revenue by Application (2020-2025)
11.4.2 Asia Afatinib Maleate Tablets Revenue by Application (2026-2031)
11.5 Asia Afatinib Maleate Tablets Revenue Share by Application (2020-2031)
11.6 Asia Afatinib Maleate Tablets Revenue by Country
11.6.1 Asia Afatinib Maleate Tablets Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Afatinib Maleate Tablets Revenue by Country (2020-2025)
11.6.3 Asia Afatinib Maleate Tablets Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Afatinib Maleate Tablets Revenue (2020-2031)
12.2 SAMEA Afatinib Maleate Tablets Revenue by Type (2020-2031)
12.2.1 SAMEA Afatinib Maleate Tablets Revenue by Type (2020-2025)
12.2.2 SAMEA Afatinib Maleate Tablets Revenue by Type (2026-2031)
12.3 SAMEA Afatinib Maleate Tablets Revenue Share by Type (2020-2031)
12.4 SAMEA Afatinib Maleate Tablets Revenue by Application (2020-2031)
12.4.1 SAMEA Afatinib Maleate Tablets Revenue by Application (2020-2025)
12.4.2 SAMEA Afatinib Maleate Tablets Revenue by Application (2026-2031)
12.5 SAMEA Afatinib Maleate Tablets Revenue Share by Application (2020-2031)
12.6 SAMEA Afatinib Maleate Tablets Revenue by Country
12.6.1 SAMEA Afatinib Maleate Tablets Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Afatinib Maleate Tablets Revenue by Country (2020-2025)
12.6.3 SAMEA Afatinib Maleate Tablets Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.